Emory Urology

Winship study paves the way for more patients to benefit from future immunotherapies.

“After doing a literature review about cystectomy patients and how devastating it is for female sexual function after having a cystectomy, [my main takeaway from this study is that] it seems that women tolerate the intravesical treatments well,” says Talia A. Helman, MD.

“Allowing these women to have a fulfilling life after cancer is one of the best things we can do as physicians,” says Talia A. Helman, MD.

“The hope is that we can collaborate with folks who might be interested in trying nadofaragene plus something else, something that compliments the mechanism of action, so that we can build upon what we have now,” says Vikram M. Narayan, MD.

"Because it takes advantage of a viral vector and is delivered as a gene therapy product, what it can do is it can have sustained release of IFNα2b in the bladder," says Vikram M. Narayan, MD.

“We’re in a very exciting time for those of us who take care of patients with bladder cancer. There are a lot of new emerging treatment options,” says Vikram M. Narayan, MD.

“We looked at MRD negative patients, MRD positive patients, and their ultimate clinical response to see if it could be predictive of recurrence-free survival,” says Vikram M. Narayan, MD.

"If we do not see people that look like us in positions of leadership, that is not a field that we're going to want to enter," says Akanksha Mehta, MD, MS.

"We are caring for a variety of patients who do not look like the physicians who are providing care to them," says Akanksha Mehta, MD, MS.

"The [SWIU meeting] is a meeting that provides updates to all of our members about the exciting initiatives that the organization has been able to accomplish in the preceding year, as well as the initiatives that are planned for the subsequent year," says Akanksha Mehta, MD, MS.

"It is a big ask of a trainee to have them sign up for a field that is demanding in terms of training, but also demanding in terms of non-professional commitments that they would otherwise make to their family life and their personal life," says Akanksha Mehta, MD, MS.

“There are not enough male reproductive health specialists across the country at the present moment,” says Akanksha Mehta, MD, MS.

“The proportion of clinics that employ an onsite urologist, where the urologist is integrated into the flow of that clinic, is relatively small,” says Akanksha Mehta, MD, MS.